AM ET/PT CAMPBELL, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing ...
VIVUS, in collaboration with PharmaAccess, its marketing partner in the Middle East North African (MENA) region, intends to provide healthcare providers with more treatment options to combat this ...
The episode will feature John Amos, Chief Executive Officer at VIVUS LLC, along with leading weight-loss experts, to discuss QSYMIA® (phentermine and topiramate extended-release capsules CIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results